News & Events about Organon Co.
Parallel Advisors LLC lifted its position in Organon Co. (NYSE:OGN Get Rating) by 55.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,563 shares of the companys stock after purchasing ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organon & Co. - OGN SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organon & Co. - OGN PR Newswire NEW YORK, Feb. 22, 2023 NEW YORK, Feb. 22, 2023 /PRNewswire...
Business Wire
3 months ago
Organon (NYSE: OGN) today announced its results for the fourth quarter and full year ended December 31, 2022. 'We enter 2023 with momentum, building off the significant achievements in our short history as an independent company,' said Kevin Ali, Organon's CEO. 'Since these products...
Business Wire
3 months ago
Organon (NYSE: OGN), a global womens healthcare company will release its fourth quarter and full year 2022 financial results on February 16, 2023, prior to the companys webcast and conference call scheduled for 8:30 a.m. EST. Interested parties may access the live call via webcast on the Organon...